In this presentation from the Lymphoma & Myeloma 2017, Dr. Peter Hillmen discusses the clinical relevance of minimal residual disease (MRD).
Earn CME credit for a related activity at the following location:
[ Ссылка ]
© 2017 Imedex, LLC.
![](https://i.ytimg.com/vi/q6YH1okqUAg/maxresdefault.jpg)
In this presentation from the Lymphoma & Myeloma 2017, Dr. Peter Hillmen discusses the clinical relevance of minimal residual disease (MRD).
Earn CME credit for a related activity at the following location:
[ Ссылка ]
© 2017 Imedex, LLC.